QUAD vs REGN · rev $2.67B vs P/E 14, rev $14.34B
Quad Graphics Inc (QUAD) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Quad Graphics Inc (QUAD) is a specialty business services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported QUAD revenue for 2024-12-31 was $2.67B. Net income was -$50.9M. Revenue was down 9.7% from 2023-12-31 to 2024-12-31. QUAD currently screens at market cap $282.4M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
QUAD currently screens at market cap $282.4M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the QUAD and REGN stock pages for the full models.
Not investment advice.